C4 Therapeutics (CCCC) Treasury Shares (2019 - 2026)
C4 Therapeutics' quarterly Treasury Shares came in at $4.5 million in Q1 2026, up 58.48% quarter-over-quarter from $2.8 million in Q4 2025.
C4 Therapeutics has reported Treasury Shares for 7 years, with the latest figure at $4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (changed N/A YoY), and the FY2025 full-year result was $2.8 million, up 2776.28% from the prior year.
- Treasury Shares for Q1 2026 stood at $4.5 million, up from $2.8 million in the prior quarter.
- The five-year high for Treasury Shares was $4.5 million in Q1 2026, with the low at $6634.0 in Q3 2024.
- Average Treasury Shares over 5 years is $1.3 million, with a median of $687140.0 recorded in 2023.
- Year-over-year, Treasury Shares plunged 99.12% in 2024 and soared 43183.48% in 2025.
- Tracing CCCC's Treasury Shares over 5 years: stood at $468316.0 in 2022, then sank by 67.12% to $154000.0 in 2023, then sank by 36.36% to $98000.0 in 2024, then jumped by 2776.28% to $2.8 million in 2025, then jumped by 58.48% to $4.5 million in 2026.
- The last three Treasury Shares figures came in at $4.5 million (Q1 2026), $2.8 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Sep 30, 2025 | 2.87 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Dec 31, 2024 | 98,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Sep 30, 2024 | 6,634.00 |
| Sep 30, 2024 | 6,634.00 |
| Dec 31, 2023 | 154,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Sep 30, 2023 | 755,960.00 |
| Sep 30, 2023 | 755,960.00 |
| Jun 30, 2023 | 687,140.00 |
| Jun 30, 2023 | 687,140.00 |
| Mar 31, 2023 | 721,520.00 |
| Mar 31, 2023 | 721,520.00 |
| Sep 30, 2022 | 468,316.00 |
| Sep 30, 2022 | 468,316.00 |
| Jun 30, 2022 | 495,817.00 |
| Jun 30, 2022 | 495,817.00 |
| Mar 31, 2022 | 563,500.00 |
| Mar 31, 2022 | 563,500.00 |
| Dec 31, 2020 | 43,972.00 |
| Dec 31, 2020 | 43,972.00 |
| Sep 30, 2020 | 20,272.00 |
| Sep 30, 2020 | 20,272.00 |
| Jun 30, 2020 | 23,714.00 |
| Jun 30, 2020 | 23,714.00 |
| Dec 31, 2019 | 6,112.00 |
| Dec 31, 2019 | 6,112.00 |
| Sep 30, 2019 | 6,112.00 |
| Sep 30, 2019 | 6,112.00 |